Interleukin-12 (IL-12) plays an important role in antigen-specific adaptive immunity against Plasmodium sporozoites, and this requirement allows for a new approach to developing an effective malaria vaccine. In this study, we examined whether IL-12 could enhance protective efficacy of a baculovirus-based malaria vaccine. 
Summary
Interleukin-12 (IL-12) plays an important role in antigen-specific adaptive immunity against Plasmodium sporozoites, and this requirement allows for a new approach to developing an effective malaria vaccine. In this study, we examined whether IL-12 could enhance protective efficacy of a baculovirus-based malaria vaccine. We previously developed a baculovirus dual expression system (BDES)
that drives malaria antigen expression by a dual promoter consisting of baculovirus-derived polyhedrin and mammal-derived cytomegalovirus (CMV) promoters. [2] [3] [4] [5] [6] [7] [8] [9] [10] This system can induce strong anti-Plasmodium immunity in animal models and has been shown to be an effective malaria vaccine platform for targeting all parasite life stages. 2-10 Recently, we successfully developed an enhanced "BDES-Spider" vaccine platform, which expresses a decay-accelerating factor on the surface of the viral envelope, resulting in a higher transduction efficacy in the presence of complement both in vitro and in vivo. 11 Importantly, a newly developed vaccine based on this platform, BDES-sPfCSP2-Spider, had a strong protective efficacy against challenge with transgenic Plasmodium berghei sporozoites expressing the Plasmodium falciparum circumsporozoite protein (PfCSP).
11
The sequence for the post-transcriptional regulatory element of woodchuck hepatitis virus (WPRE) is a strong cis-acting RNA element located in the viral 3′ untranslated region (3′ UTR). WPRE improves gene expression at the post-transcriptional level by modifying RNA polyadenylation. 12 Insertion of the WPRE sequence into the 3′ UTR of transgenes in an influenza DNA vaccine induced strong antigen expression in host cells, followed by a high level of protective immunity.
13
The WPRE also significantly boosted baculovirus-mediated transgene expression in mammalian cells. 14, 15 
| MATERIALS AND METHODS

| Vaccine construction
For the construction of a gene cassette expressing the sPfCSP2-VSV-G TM fusion protein under dual-promoter control with the WPRE sequence, the WPRE sequence was synthesized by Genscript 
, pFast-GL3-Spider and pFast-mIL12-Spider were generated by LR clonase reactions using LR clonase II (Thermo Fisher Scientific Inc., Pittsburgh, PA, USA) with the above donor vectors and destination vectors according to the manufacturer's instructions.
Recombinant bacmids were generated by Tn7-mediated transposition of the gene cassettes in pFast vectors (pFast-sPfCSP2-Spider, pFastsPfCSP2-WPRE-Spider, pFast-GL3-Spider and pFast-mIL-12-Spider) using the Bac-to-Bac system (Thermo Fisher Scientific) according to the manufacturer's instructions. Amplification and purification of the baculoviruses were performed as described previously. (Rockland Immunochemicals, Gilbertsville, PA) were visualized using an Odyssey infrared imager (LI-COR, Lincoln, NE). An anti-GAPDH mouse mAb (5A12, Wako, Osaka, Japan) was used as a loading control to the same membrane. 
| Indirect fluorescent assay
| Enzyme-linked immunosorbent assay (ELISA)
For
| PfCSP-Tc/Pb sporozoite challenge
Balb/c mice were immunized intramuscularly two or three times at 3-week intervals with 10 8 pfu of the viral-vectored vaccines. The method used for the sporozoite challenge infections, which involved infected mosquito bites, was performed as described previously. Briefly, Anopheles stephensi mosquitoes were infected with PfCSP-Tc/ Pb, which are transgenic Plasmodium berghei parasites expressing PfCSP instead of P. berghei CSP. 8 The starved infected mosquitoes were allowed to feed on the abdomen of each mouse for 15 minutes.
All of the mosquitoes were subsequently examined by dissection for extraction of midguts and salivary glands post-bite. Mosquitoes that had a blood spot in the midgut were deemed to have fed, whereas presence of sporozoites in the salivary glands was used to identify infected mosquitoes. All animal care and handling procedures were approved by the Animal Care and Use Committee of Kanazawa University (No. 22118-1). In the UK, all procedures were performed in accordance with the UK Animals (Scientific Procedures) Act (PPL 70/8788) and approved by Imperial College AWERB. All efforts were made to minimize suffering in the animals.
| Statistical analyses
A two-tailed Fisher's exact probability test was performed to determine statistical differences in the protective efficacies of the vaccines 
| RESULTS
Aiming to enhance PfCSP expression in transduced cells, we introduced the WPRE sequence after the PfCSP-VSV-G open-reading frame in a transfer vector of BDES, pFast-D-sPfCSP2-Spider ( Figure 1A ). This sequence is a noncoding RNA sequence that acts to increase mRNA stability and its extranuclear transport to the cytoplasm. 13 The resulting plasmid, pFast-D-sPfCSP2-WPRE-Spider, induced PfCSP expression levels in HEK293A cells that were 3.3-fold The sera of the immunized mice described in Table 1 Spider group § to test for statistically significant differences using a Fisher's exact probability test (P < .05). The challenge infection was conducted as described in Table 1 . b,c Each group of immunized mice was compared with the BES-GL3-Spider group b or BDES-sPfCSP2-WPRE-Spider group c to test for statistically significant differences using a Fisher's exact probability test (P< .05). d Protective efficacy was calculated as described in Table 1 . The challenge infection was conducted as described in Table 1. b
Protective efficacy was calculated as described in Table 1 , and mean protective efficacy is shown as an average of two independent experiments. Plasmodium. 17 We found that co-immunization with BDES-sPfCSP2-WPRE-Spider and BES-mIL-12-Spider resulted in a significant improvement (80% protection) over immunization with BDES-sPfCSP2-Spider alone (P = .005 using a chi-square test). Our recent studies showed that CD8 + memory T cells against PfCSP were not induced in mice by co-immunization with BDES and BES-mIL-12-Spider (data not shown).
Here, protected mice in the BDES-vaccinated group did not have a significantly higher Ab response than nonprotected mice in this group (Figure 3) , indicating that the Ab responses were not correlated with protection; both of these findings are consistent with previous work. 
